Levosimendan and Myocardial Protection

NCT00610350 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Protection

Interventions

DRUG: levosimendan
DRUG: Placebo

Sponsor

University of Roma La Sapienza

Collaborators

[object Object]